The Patent Finder
US

Methods for Lowering Elevated Uric Acid Levels Using Intravenous Injections of Peg-Uricase

US 8,148,123 In force
OverviewFamilyAssignmentsSources & methods

Also listed on Horizon Pharma Rheumatology LLC, an earlier holder on the record. The recorded assignments below show how it moved.

Term ends Sep 8, 2027 · Medium confidence

Why Medium: A parent in the chain could not be resolved.

Filed Oct 6, 2006 as application 11/539,475 · Granted Apr 3, 2012
Base term plus 515 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2006 2027
Clock starts
Apr 11, 2006
Term ends
Sep 8, 2027
Granted
Apr 3, 2012
base term patent term adjustment fee events Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
515
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
22
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term runs 515 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Apr 11, 2006, when applications PCT/US2006/013502 and PCT/US2006/013660, the earliest non-provisional applications in its chain, were filed (this one was filed Oct 6, 2006); a parent in its chain could not be resolved (the next row)Apr 11, 2026High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustment+515 days, USPTO patent term adjustment recordSep 8, 2027High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderSep 8, 2027Medium confidence

Partial family

Application PCT/US2006/013502PCT application
no patent term
no patent term
Application PCT/US2006/013660PCT application
no patent term
no patent term
US 8,148,123this patent
Sep 2027
Sep 2027
Application 11/899,688Abandoned
not computed
not computed
US 7,811,800Term ended
Apr 2026
Apr 2026
US 8,188,224Term ended
Apr 2026
Apr 2026
US 7,964,381Term ended
Apr 2026
Apr 2026
US 8,034,594Term ended
Apr 2026
Apr 2026
8 of 22 applications in this family shown, earliest filings first. Partial: 2 of the 22 have no file history here, so a row comes from the patent's own record or names the application alone. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Aug 28, 2007
Reel 19756, frame 45
Rehrig, Claudia D.; Huang, William; Hartman, Jacob; Mendelovitz, SimonaSavient Pharmaceuticals, Inc.Assignment of Assignor's Interest
Jul 23, 2008
Reel 21278, frame 683
Hershfield, Michael S.Duke UniversityAssignment of Assignor's Interest
Jun 12, 2012
Reel 28363, frame 40
Savient Pharmaceuticals, Inc.Morgan Stanley Senior Funding Inc.Security Agreement
Jul 23, 2013
Reel 30936, frame 72
Savient Pharmaceuticals, Inc.U.S. National Bank Association, as Collateral AgentCorrective Assignment to Correct the Receiving Party Previously Recorded on Reel 028363 Frame 0040. Assignor(S) Hereby Confirms the Security Agreement.
Feb 21, 2014
Reel 32319, frame 77
Crealta Pharmaceuticals LLCJefferies Finance LLC, as Collateral AgentSecurity Agreement
Mar 4, 2014
Reel 32384, frame 285
Crealta Pharmaceuticals LLCFifth Street Finance Corp., as Collateral AgentSecurity Agreement
Aug 18, 2015
Reel 36388, frame 167
Savient Pharmaceuticals, Inc.Crealta Pharmaceuticals LLCAssignment of Assignor's Interest
Jan 13, 2016
Reel 37483, frame 49
Fifth Street Finance Corp., as Collateral AgentCrealta Pharmaceuticals LLCRelease of Security Interest
Jan 13, 2016
Reel 37483, frame 148
Jefferies Finance LLC, as Collateral AgentCrealta Pharmaceuticals LLCRelease of Security Interest
Sep 16, 2016
Reel 40059, frame 7
Horizon Pharma Rheumatology LLC (Formerly Known as Crealta Pharmaceuticals LLC)Citibank, N.A., as Collateral AgentPatent Security Agreement
Nov 18, 2016
Reel 40648, frame 361
Crealta Pharmaceuticals LLCHorizon Pharma USA Rheumatology LLCChange of Name
Nov 18, 2016
Reel 40648, frame 367
Horizon Pharma USA Rheumatology LLCHorizon Pharma Rheumatology LLCChange of Name
Oct 31, 2022
Reel 61805, frame 76
Horizon Pharma Rheumatology LLCHorizon Therapeutics USA, Inc.Assignment of Assignor's Interest
Dec 1, 2022
Reel 62073, frame 930
Horizon Pharma Rheumatology LLCHorizon Therapeutics USA, Inc.Corrective Assignment to Correct the Name of the Assignee Previously Recorded on Reel 061805 Frame 0076. Assignor(S) Hereby Confirms the Assignment.
Oct 6, 2023
Reel 65178, frame 965
Citibank, N.a.Horizon Therapeutics USA, Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited